Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | Using genomic techniques to guide personalized medicine in breast cancer

Serafin Morales • 19 May 2020
ESMO Breast 2020
Breast Cancer

Serafin Morales, PhD, of the University Hospital Arnau de Vilanova, Lleida, Spain, discusses how genetic tools can guide personalized medicine in breast cancer treatment as well identify genetic changes that occur as a result of treatment that may mediate resistance. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Serafin Morales

1:01
Chemo-immunotherapy for TNBC
Serafin Morales • 12 May 2020
4:37
Latest advances in breast cancer research
Serafin Morales • 12 May 2020
2:17
Loss of HER2 after neoadjuvant treatment of HER2+ early BC
Serafin Morales • 13 May 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals